• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕中期甲胎蛋白水平在低出生体重筛查中的应用

Mid-trimester levels of alphafetoprotein in the screening of low birthweight.

作者信息

Chard T, Rice A, Kitau M J, Hird V, Grudzinskas J G, Nysenbaum A M

出版信息

Br J Obstet Gynaecol. 1986 Jan;93(1):36-8. doi: 10.1111/j.1471-0528.1986.tb07810.x.

DOI:10.1111/j.1471-0528.1986.tb07810.x
PMID:2417618
Abstract

Elevated maternal levels of alphafetoprotein (AFP) in midtrimester are believed by some to be a useful screening test for premature labour, low birthweight and low birthweight for gestation. In a prospective study on 887 randomly selected pregnant women we found that although there was an association between low birthweight and elevated AFP, the test would miss five out of every six cases of low birthweight and there would be nine false-positives for every case correctly identified. The test is not therefore sufficiently predictive of low birthweight to be of value as a screening test for this condition.

摘要

一些人认为,孕中期孕妇甲胎蛋白(AFP)水平升高是早产、低出生体重和小于胎龄儿低出生体重的有效筛查指标。在一项对887名随机选择的孕妇进行的前瞻性研究中,我们发现,虽然低出生体重与AFP升高之间存在关联,但该检测每六例低出生体重病例中会漏诊五例,且每正确识别一例就会有九例假阳性。因此,该检测对低出生体重的预测性不足,不能作为这种情况的筛查检测。

相似文献

1
Mid-trimester levels of alphafetoprotein in the screening of low birthweight.孕中期甲胎蛋白水平在低出生体重筛查中的应用
Br J Obstet Gynaecol. 1986 Jan;93(1):36-8. doi: 10.1111/j.1471-0528.1986.tb07810.x.
2
Obstetrical complications associated with abnormal maternal serum markers analytes.与母体血清标志物分析物异常相关的产科并发症。
J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5.
3
Maternal plasma alpha-fetoprotein and low birthweight: a prospective study throughout pregnancy.
Br J Obstet Gynaecol. 1982 May;89(5):348-51. doi: 10.1111/j.1471-0528.1982.tb05076.x.
4
A semi-automated serum alphafetoprotein radioimmunoassay for prenatal spina bifida screening.一种用于产前脊柱裂筛查的半自动血清甲胎蛋白放射免疫测定法。
Br J Obstet Gynaecol. 1975 Sep;82(9):718-27. doi: 10.1111/j.1471-0528.1975.tb00712.x.
5
High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age.孕妇血清甲胎蛋白水平高与低出生体重。一项关于孕妇体重、吸烟、血清甲胎蛋白与后续出生体重和孕周之间可能存在的相关性的研究。
Am J Perinatol. 1985 Apr;2(2):78-81. doi: 10.1055/s-2007-999919.
6
Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.泰国孕妇孕中期唐氏综合征血清筛查假阳性后的不良妊娠结局
J Med Assoc Thai. 2005 Apr;88(4):449-54.
7
Alphafetoprotein in midtrimester Down's syndrome fetal serum.
J Med Genet. 1990 Apr;27(4):240-3. doi: 10.1136/jmg.27.4.240.
8
Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.孕中期唐氏综合征产前筛查及孕妇血清生化标志物与不良结局妊娠并发症的关系。
Prenat Diagn. 2000 Aug;20(8):652-6.
9
[Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].高龄孕妇孕中期血清学筛查唐氏综合征:一项多中心前瞻性研究
Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):737-41.
10
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.孕中期唐氏综合征筛查项目中联合母体血清甲胎蛋白和人绒毛膜促性腺激素的有效性。
Obstet Gynecol. 1994 Aug;84(2):298-303.

引用本文的文献

1
Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.使用唐氏综合征标志物进行血清筛查以预测子痫前期和小于胎龄儿:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2008 Aug 4;8:33. doi: 10.1186/1471-2393-8-33.
2
The effects on fetal development of high alpha-fetoprotein and maternal smoking.高甲胎蛋白和孕妇吸烟对胎儿发育的影响。
Am J Public Health. 1999 Apr;89(4):561-3. doi: 10.2105/ajph.89.4.561.